• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌驱动基因和肿瘤微环境决定肝癌的类型。

Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.

机构信息

Department of General Surgery, The 74th Group Army Hospital, Guangzhou, 510220, China.

Department of General Surgery, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.

出版信息

Cell Death Dis. 2020 May 4;11(5):313. doi: 10.1038/s41419-020-2509-x.

DOI:10.1038/s41419-020-2509-x
PMID:32366840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198508/
Abstract

Primary liver cancer (PLC) may be mainly classified as the following four types: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatoblastoma (HB), and combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (cHCC-ICC). The majority of PLC develops in the background of tumor microenvironment, such as inflammatory microenvironments caused by viral hepatitis, alcoholic or nonalcoholic steatohepatitis, carbon tetrachloride (CCl), 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), and necroptosis-associated hepatic cytokine microenvironment caused by necroptosis of hepatocytes. However, the impact of different types of microenvironments on the phenotypes of PLC generated by distinct oncogenes is still unclear. In addition, the cell origin of different liver cancers have not been clarified, as far as we know. Recent researches show that mature hepatocytes retain phenotypic plasticity to differentiate into cholangiocytes. More importantly, our results initially demonstrated that HCC, ICC, and cHCC-ICC could originate from mature hepatocytes rather than liver progenitor cells (LPCs), hepatic stellate cells (HSCs) and cholangiocytes in AKT-driven, AKT/NICD-driven and AKT/CAT-driven mouse PLC models respectively by using hydrodynamic transfection methodology. Therefore, liver tumors originated from mature hepatocytes embody a wide spectrum of phenotypes from HCC to CC, possibly including cHCC-ICC and HB. However, the underlying mechanism determining the cancer phenotype of liver tumors has yet to be delineated. In this review, we will provide a summary of the possible mechanisms for directing the cancer phenotype of liver tumors (i.e., ICC, HCC, and cHCC-ICC) in terms of oncogenic driver genes and tumor microenvironment. Moreover, this study initially revealed the cell origin of different types of liver cancer.

摘要

原发性肝癌(PLC)主要可分为以下四种类型:肝细胞癌(HCC)、肝内胆管细胞癌(ICC)、肝母细胞瘤(HB)以及肝细胞癌和肝内胆管细胞癌混合型(cHCC-ICC)。大多数 PLC 的发生都与肿瘤微环境有关,如病毒性肝炎、酒精性或非酒精性脂肪性肝炎、四氯化碳(CCl)、3,5-二乙氧基羰基-1,4-二氢吡啶(DDC)引起的炎症微环境,以及由肝细胞坏死引起的与坏死相关的肝细胞细胞因子微环境。然而,不同类型的微环境对不同致癌基因引起的 PLC 表型的影响仍不清楚。此外,就我们所知,不同肝癌的细胞起源尚未阐明。最近的研究表明,成熟肝细胞保留向胆管细胞分化的表型可塑性。更重要的是,我们的研究结果初步表明,在 AKT 驱动、AKT/NICD 驱动和 AKT/CAT 驱动的小鼠 PLC 模型中,HCC、ICC 和 cHCC-ICC 分别来源于成熟肝细胞,而不是肝祖细胞(LPCs)、肝星状细胞(HSCs)和胆管细胞,我们通过使用水力转染方法证实了这一结果。因此,起源于成熟肝细胞的肝肿瘤表现出从 HCC 到 CC 的广泛表型,可能包括 cHCC-ICC 和 HB。然而,决定肝肿瘤癌症表型的潜在机制尚未阐明。在本综述中,我们将根据致癌驱动基因和肿瘤微环境,为肝肿瘤(即 ICC、HCC 和 cHCC-ICC)的癌症表型提供可能的机制总结。此外,本研究初步揭示了不同类型肝癌的细胞起源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/9eb0a4d8133c/41419_2020_2509_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/39303c3cfae9/41419_2020_2509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/cbe24e38a338/41419_2020_2509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/f9521a6e9003/41419_2020_2509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/fab9582adbe9/41419_2020_2509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/f5e38b3eabbd/41419_2020_2509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/867e72143c27/41419_2020_2509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/d310f1c29ab0/41419_2020_2509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/9eb0a4d8133c/41419_2020_2509_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/39303c3cfae9/41419_2020_2509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/cbe24e38a338/41419_2020_2509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/f9521a6e9003/41419_2020_2509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/fab9582adbe9/41419_2020_2509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/f5e38b3eabbd/41419_2020_2509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/867e72143c27/41419_2020_2509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/d310f1c29ab0/41419_2020_2509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b64/7198508/9eb0a4d8133c/41419_2020_2509_Fig8_HTML.jpg

相似文献

1
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.致癌驱动基因和肿瘤微环境决定肝癌的类型。
Cell Death Dis. 2020 May 4;11(5):313. doi: 10.1038/s41419-020-2509-x.
2
Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.揭示坏死性凋亡微环境的作用:FCGBP+肿瘤相关巨噬细胞驱动原发性肝癌向胆管细胞型肝细胞癌或肝内胆管癌分化。
Apoptosis. 2024 Apr;29(3-4):460-481. doi: 10.1007/s10495-023-01908-3. Epub 2023 Nov 28.
3
Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.肿瘤微环境:坏死性凋亡改变肝癌亚型,而坏死促进肿瘤复发和进展。
Exp Clin Transplant. 2023 Apr;21(4):291-298. doi: 10.6002/ect.2021.0457. Epub 2022 Mar 15.
4
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.Notch2 控制小鼠肝细胞源性胆管癌的形成。
Oncogene. 2018 Jun;37(24):3229-3242. doi: 10.1038/s41388-018-0188-1. Epub 2018 Mar 16.
5
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.一种新型的肝细胞癌和肝内胆管细胞癌合并的小鼠模型。
J Transl Med. 2022 Dec 9;20(1):579. doi: 10.1186/s12967-022-03791-z.
6
Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.IDH1R132C突变体在小鼠胆管癌发生中的致癌潜力。
World J Gastroenterol. 2016 Feb 14;22(6):2071-80. doi: 10.3748/wjg.v22.i6.2071.
7
Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.描述肝细胞癌和肝内胆管癌之间独特的免疫微环境。
Cancer Lett. 2024 Apr 28;588:216799. doi: 10.1016/j.canlet.2024.216799. Epub 2024 Mar 11.
8
Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.p53 基因敲除小鼠中转分化和去分化产生的肝细胞胆管细胞癌。
Cancer Sci. 2021 Aug;112(8):3111-3124. doi: 10.1111/cas.14996. Epub 2021 Jun 27.
9
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.混合型肝细胞癌:从发生机制到分子通路和治疗策略。
J Cancer Res Clin Oncol. 2024 May 23;150(5):270. doi: 10.1007/s00432-024-05781-8.
10
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype.致癌驱动基因和炎性微环境决定肝肿瘤表型。
Hepatology. 2016 Jun;63(6):1888-99. doi: 10.1002/hep.28487. Epub 2016 Mar 15.

引用本文的文献

1
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma.基于转化生长因子-β信号通路的血清蛋白质组学特征可对肝细胞癌风险进行分层。
Liver Int. 2025 Oct;45(10):e70325. doi: 10.1111/liv.70325.
2
Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors.肝细胞癌干细胞:基于小分子抑制剂的研究现状
Cell Death Dis. 2025 Sep 1;16(1):666. doi: 10.1038/s41419-025-07983-5.
3
Integrated analysis of single cell and spatial transcriptomics revealed a metastasis mechanism mediated by fatty acid metabolism in lymph nodes of head and neck cancer.

本文引用的文献

1
The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.马兜铃酸诱导的小鼠和人肝癌的突变特征。
Hepatology. 2020 Mar;71(3):929-942. doi: 10.1002/hep.30863. Epub 2019 Nov 6.
2
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities.肝细胞癌的靶向治疗:挑战与机遇。
Cancer Lett. 2019 Sep 28;460:1-9. doi: 10.1016/j.canlet.2019.114428. Epub 2019 Jun 15.
3
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.Fbxw7 缺失与激活的 Akt 信号协同作用,促进 c-Myc 依赖性胆管癌发生。
单细胞和空间转录组学的综合分析揭示了头颈癌淋巴结中由脂肪酸代谢介导的转移机制。
Front Immunol. 2025 Aug 13;16:1614498. doi: 10.3389/fimmu.2025.1614498. eCollection 2025.
4
LncRNA938/ TAF9/TTK axis promotes EMT and serves as a therapeutic target in hepatoblastoma.长链非编码RNA938/TAF9/TTK轴促进上皮-间质转化并作为肝母细胞瘤的治疗靶点。
J Transl Med. 2025 Aug 21;23(1):946. doi: 10.1186/s12967-025-06809-4.
5
Can Peritumoral Radiomics Based on MRI Predict the Microvascular Invasion Status of Combined Hepatocellular Carcinoma and Cholangiocarcinoma Before Surgery?基于MRI的瘤周放射组学能否预测肝内胆管癌合并肝细胞癌术前微血管侵犯状态?
J Hepatocell Carcinoma. 2025 Jul 16;12:1441-1452. doi: 10.2147/JHC.S515651. eCollection 2025.
6
Identification of a novel FOXO3‑associated prognostic model in hepatocellular carcinoma.肝细胞癌中一种新型FOXO3相关预后模型的鉴定
Oncol Lett. 2025 Mar 13;29(5):230. doi: 10.3892/ol.2025.14976. eCollection 2025 May.
7
Multiple-omics analysis reveals a dedifferentiation-immune loop in intrahepatic cholangiocarcinoma.多组学分析揭示肝内胆管癌中的去分化-免疫循环。
Mol Ther. 2025 Apr 2;33(4):1803-1824. doi: 10.1016/j.ymthe.2025.02.019. Epub 2025 Feb 12.
8
Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies.使用整合生物信息学方法和机器学习策略识别肝细胞癌中免疫细胞的潜在特征。
Immunol Res. 2025 Feb 4;73(1):46. doi: 10.1007/s12026-024-09585-3.
9
Analysis of the implication of steroid 5 alpha-reductase 3 on prognosis and immune microenvironment in Liver Hepatocellular Carcinoma.类固醇 5α-还原酶 3 对肝癌预后和免疫微环境的意义分析。
Ann Med. 2024 Dec;56(1):2408463. doi: 10.1080/07853890.2024.2408463. Epub 2024 Sep 28.
10
Thiostrepton as a Potential Therapeutic Agent for Hepatocellular Carcinoma.硫链丝菌素作为一种潜在的肝癌治疗药物。
Int J Mol Sci. 2024 Sep 8;25(17):9717. doi: 10.3390/ijms25179717.
J Hepatol. 2019 Oct;71(4):742-752. doi: 10.1016/j.jhep.2019.05.027. Epub 2019 Jun 11.
4
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints.缺氧肿瘤微环境和肿瘤细胞可塑性对免疫检查点表达的影响。
Cancer Lett. 2019 Aug 28;458:13-20. doi: 10.1016/j.canlet.2019.05.021. Epub 2019 May 25.
5
Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.阻断 NF-κB 信号通路可加速 MYC 驱动的肝细胞癌发生,并使肿瘤表型向肝细胞胆管细胞癌转变。
Cancer Lett. 2019 Aug 28;458:113-122. doi: 10.1016/j.canlet.2019.05.023. Epub 2019 May 22.
6
Focal Adhesion Kinase and β-Catenin Cooperate to Induce Hepatocellular Carcinoma.黏着斑激酶和β-连环蛋白协同诱导肝细胞癌。
Hepatology. 2019 Nov;70(5):1631-1645. doi: 10.1002/hep.30707. Epub 2019 Jun 22.
7
Necroptosis microenvironment directs lineage commitment in liver cancer.细胞焦亡微环境指导肝癌细胞谱系分化。
Nature. 2018 Oct;562(7725):69-75. doi: 10.1038/s41586-018-0519-y. Epub 2018 Sep 12.
8
Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment.设计水凝胶:揭示胰腺癌微环境的物理化学特性。
Cancer Lett. 2018 Nov 1;436:22-27. doi: 10.1016/j.canlet.2018.08.008. Epub 2018 Aug 14.
9
FBXW7: a critical tumor suppressor of human cancers.FBXW7:人类癌症的关键肿瘤抑制因子。
Mol Cancer. 2018 Aug 7;17(1):115. doi: 10.1186/s12943-018-0857-2.
10
Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.分离癌相关成纤维细胞及其促进肝内胆管癌的进展。
Cancer Med. 2018 Sep;7(9):4665-4677. doi: 10.1002/cam4.1704. Epub 2018 Jul 31.